Stephan Kirschbaum
Corporate Officer/Principal bij DOTTIKON ES HOLDING AG
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Stephan Kirschbaum
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DOTTIKON ES HOLDING AG | Corporate Officer/Principal | 01-01-2009 | - |
| Dottikon Es America, Inc. | Chief Executive Officer | - | - |
| Chairman | - | - | |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - | - |
Loopbaan van Stephan Kirschbaum
Eerdere bekende functies van Stephan Kirschbaum
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| UBS | Corporate Officer/Principal | 01-01-2005 | 01-01-2009 |
| Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | 01-01-1999 | 01-01-2005 |
| University of California, Santa Barbara | Chief Tech/Sci/R&D Officer | 01-01-1997 | 01-01-1999 |
Opleiding van Stephan Kirschbaum
| University of Karlsruhe | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 5 |
| Duitsland | 3 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Bedrijven in privébezit | 4 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es America, Inc. | |
| Mckinsey & Co., Inc. (Germany) |
- Beurs
- Insiders
- Stephan Kirschbaum
- Ervaring
